Skip to content

A prospective randomized controlled trial for early massive peritoneal irrigation for acute pancreatitis

A prospective randomized controlled trial for early massive peritoneal irrigation for acute pancreatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025205
Enrollment
Unknown
Registered
2019-08-16
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Group 2:abdominal flushing drainage group+ common medical treatment group
Group 1:common medical treatment

Sponsors

the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: According to the 2012 International Pancreatic Disease Association, the classification of acute pancreatitis, the Atlanta Classification Standard (Revised Edition) will be accompanied by abdominal muscle tension, abdominal tenderness, rebound tenderness and mild acute pancreatitis with aggravating tendency, moderately severe Acute pancreatitis and patients with severe acute pancreatitis

Exclusion criteria

Exclusion criteria: (1) Patients 80 years of age; (2) Do not sign informed consent; (3) Pregnancy and lactation women; (4) Patients with severe bleeding tendency (platelets <30×10^9/L) and hemophilia patients; (5) Life expectancy <6 months, unable to reach the 6-month follow-up period (malignant tumor or other serious diseases); (6) History of recent abdominal surgery; (7) Abdominal trauma or serious infection; (8) Traumatic pancreatitis; (9) Patients who have been included in other studies that may have an impact on the study.

Design outcomes

Primary

MeasureTime frame
28-day cure rate of acute pancreatitis;

Countries

China

Contacts

Public ContactTongwen Sun; Bingrong Liu

the First Affiliated Hospital of Zhengzhou University

bingrongliu@qq.com+86 13838516916 /15713815559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026